Fiocruz

Oswaldo Cruz Foundation an institution in the service of life

Início do conteúdo

Diagnosis of human cell lymphotropic virus HTLV-1/2 infection

Innovation Portfolio
Diagnosis of human cell lymphotropic virus HTLV-1/2 infection
Download as PDF: | Share:

Problem

There is a lack of methodologies for the universal and differential diagnosis of HTLV-1/2 (human T-cell lymphotropic virus). The high cost of the tests available for the differential diagnosis of HTLV-1/2 infection represents a major challenge in controlling diseases associated with this virus, such as leukemia and neurological problems. It is estimated that there are more than 10 million cases of HTLV in the world.

Solution

The technology consists of a serological immunofluorescence method using flow cytometry for the universal and differential diagnosis of HTLV-1 and HTLV-2 infection. The solution is based on the simultaneous analysis of IgG1 antibody reactivity. The method allows confirmatory diagnosis of the disease in just one step, without the need to collect different types and samples. This methodology can still be used as a more accurate prognosis for the patient. In other words, it is possible to check how the disease progresses in each patient.

Differential


apps
Single platform
center_focus_strong
High sensitivity and specificity
face
Easy execution

Development stage


What we are searching for

Technology licensing agreement

Inventors

Olindo Assis Martins Filho
Andrea Teixeira de Carvalho
Kelly Alves Bicalho Carvalho
Jordana Grazziela Alves Coelho dos Reis
Vanessa Peruhype Magalhães Pascoal

Intellectual Property

Type
Invention Patent
Description
Patent application filed in Brazil

 

 

 

Use your phone camera to scan the QR Code:

 

Campus Fiocruz Maré - Av. Brasil, 4036 - Maré, Rio de Janeiro - RJ

CEP: 21040-361

     
  portfolio@fiocruz.br 
     
  +55 (21) 3282-9080 

 

   
   
   

 

Back to the topBack